FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds with structural formula (I) in form of (2-exo-3-exo)cis-racemate or diastereomer with structural formula (1a) and pharmaceutically acceptable salts thereof, having antiproliferative action and aurora-kinase inhibiting properties. In formulae (I) and (1a), each R1 is hydrogen; each R2 is independently selected from a group comprising a hydrogen atom, lower alkyl and ; each R3 is independently selected from a group comprising a hydrogen atom, lower alkyl and ; each R4 is independently selected from a group comprising a hydrogen atom and lower alkyl; R5 is a halogen atom.
EFFECT: invention also relates to a pharmaceutical composition, methods of inhibiting proliferation of tumour cells, activity of aurora-kinase, an aurora-kinase mediated process, a method of treating an aurora-kinase mediated disease and use of said compounds to prepare a medicinal agent.
43 cl, 4 dwg, 4 tbl, 14 ex
Title | Year | Author | Number |
---|---|---|---|
SELECTIVE INHIBITORS OF Haspin kinase | 2012 |
|
RU2548363C2 |
PRODRUGS OF 2,4-PYRIMIDINE DIAMINE COMPOUNDS AND USE THEREOF | 2006 |
|
RU2416616C2 |
PHARMACEUTICAL COMBINATION CONTAINING ALK INHIBITOR AND SHP2 INHIBITOR | 2018 |
|
RU2769132C2 |
THERAPEUTIC COMPOUNDS AND COMPOSITIONS AND METHODS OF USING THEM | 2018 |
|
RU2769696C2 |
TETRAHYDROPYRANYL AMINO-PYRROLOPYRIMIDINONE AND METHODS OF ITS USE | 2020 |
|
RU2747991C1 |
SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS | 2011 |
|
RU2606514C2 |
TETRAHYDROPYRANYL AMINO-PYRROLOPYRIMIDINONE AND METHODS FOR USE THEREOF | 2015 |
|
RU2715421C2 |
COMPOUNDS SUITABLE FOR THERAPY AGAINST HIV | 2019 |
|
RU2806030C2 |
AMINOPYRAZOLES AS SELECTIVE JANUS KINASE INHIBITORS | 2017 |
|
RU2757218C2 |
COMPOSITIONS AND METHODS FOR JAK PATH INHIBITION | 2011 |
|
RU2672100C2 |
Authors
Dates
2011-04-20—Published
2005-11-15—Filed